Aptose Biosciences (NASDAQ:APTO) Earns Sell Rating from Analysts at StockNews.com
Investment analysts at StockNews.com started coverage on shares of Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) in a research note issued to investors on Wednesday. The firm set a “sell” rating on the biotechnology company’s stock. Several other equities research analysts also recently weighed in on APTO. Alliance Global Partners upgraded shares of Aptose […]
Investment analysts at StockNews.com started coverage on shares of Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) in a research note issued to investors on Wednesday. The firm set a “sell” rating on the biotechnology company’s stock. Several other equities research analysts also recently weighed in on APTO. Alliance Global Partners upgraded shares of Aptose […]
